Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2016 Q2- Text added to 2016 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Good
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
aflibercept, aim, area, Axtria, cap, CDER, Chadha, clarify, comfortable, comprised, cousin, cure, cycle, diabetic, digit, discontinued, diversity, edema, escalating, escalation, Eylea, forecasted, frequently, Jaswinder, lacrimal, largest, Master, modulate, mutually, oedema, passing, prerequisite, Regeneron, renovate, resorbing, resubmission, retinal, retinovascular, sublicense, survey, tear, teen, tiered, toxicology, tradename, trap, twelve, unchanged, uncured, undergo, upfront, vein, week
Valuein 2016 Q2 filing- Value in 2016 Q3 filing
Original filings
Filing view